title: Orbital cysticercosis, case report and review.
abstract: Orbital cysticercosis is secondary to an infestation by cysticercus cellulosae, the larval form of Taenia solium.Orbital cysticercosis may present with a wide spectrum of clinical findings and result in significant ocular morbidity. Although traditionally thought to be only prevalent in endemic regions with poor sanitation, immigration requires even ophthalmologists practicing in industrialised counties to be aware of this masquerading condition's presentation and treatment.We report the clinical manifestation of a case of orbital cysticersosis that presented with recurrent orbital inflammation for almost a year. We also present a literature review of the different ocular manifestations, diagnostic and treatment modalities.
authors.affiliation: Department of Ophthalmology, University College London Hospital, United Kingdom. M.ziaei@doctors.org.uk
authors.forename: Mohammed
authors.initials: M
authors.lastname: Ziaei
authors.forename: Mostafa
authors.initials: M
authors.lastname: Elgohary
authors.forename: Fion D
authors.initials: FD
authors.lastname: Bremner
mesh_terms: D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D003551:Cysticercosis / Q000175:diagnosis* / Q000188:drug therapy*; D003552:Cysticercus / Q000302:isolation & purification*; D004359:Drug Therapy, Combination; D015822:Eye Infections, Parasitic / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009916:Orbital Diseases / Q000175:diagnosis / Q000188:drug therapy; D011223:Praziquantel / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D035583:Rare Diseases; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D011223:Praziquantel; D011239:Prednisolone; D015766:Albendazole